Trials / Completed
CompletedNCT03015038
Study of the Immune Response in Colon Adenocarcinoma
Etude de la réponse Immunitaire Dans l'adénocarcinome Colique
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Duration of each part of the study per patient: * Screening: From 1 to 4 weeks * Sampling period (blood and tissue): 1 day * Follow-up by patient: 60 months * Total study duration by patient: 84 months * Total inclusion duration: 24 months * Total Follow-up duration: 60 months * Total study duration: 84 months
Conditions
Timeline
- Start date
- 2017-02-05
- Primary completion
- 2024-02-05
- Completion
- 2024-02-05
- First posted
- 2017-01-09
- Last updated
- 2025-12-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03015038. Inclusion in this directory is not an endorsement.